what is a glp-1 program The revolution: UAB researchers are discovering about how these drugs work GLP-1 receptor agonists | How

Sub-therapeutic dosing may produce no noticeable effects, positive or negative

Large-scale randomized controlled trials to assess the long-term efficacy and safety of current and emerging interventions

Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis

Available online at: 45

Patients with obesity-related comorbidities have higher disability compared with those without obesity-related comorbidities: results from a cross-sectional study

Discussion Targeted proteomics was used to evaluate potential markers of type 1 diabetes in youth from the first 100 ND individuals recruited to the INNODIA study